Skip to content

OptimizeRx OPRX Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Spok Holdings logo
Spok HoldingsSPOK
Veeva Systems logo
Veeva SystemsVEEV
Phreesia logo
PhreesiaPHR
Doximity logo
DoximityDOCS
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
PubMatic logo
PubMaticPUBM

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's operating lease right-of-use assets in other assets?
OptimizeRx (OPRX) reported operating lease right-of-use assets in other assets of $352K in Q1 2026.
How has OptimizeRx's operating lease right-of-use assets in other assets changed year-over-year?
OptimizeRx's operating lease right-of-use assets in other assets increased by 16.2% year-over-year, from $303K to $352K.
What is the long-term trend for OptimizeRx's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), OptimizeRx's operating lease right-of-use assets in other assets has grown at a -2.0% compound annual growth rate (CAGR), from $445.97K to $404K.